|
|
Market Dynamics 2001: Antidepressants - Absorbing the Impact of Generic ProzacPublished by: Datamonitor Published: Dec. 21, 2001 - 255 Pages Table of ContentsDATAMONITOR HEALTHCARE EXECUTIVE SUMMARY Scope Datamonitor insight into the antidepressant market The impact of generic Prozac has ensured that pharmaceutical manufacturers who market SSRIs must develop early protection strategies against US patent expiry Noradrenergic antidepressants grew strongly in every major healthcare market in 2000. Consequently, they will play an increasingly important role in driving market growth as physicians seek alternatives to the SSRIs and patent expiries lower rival products' marketing spend Cost constraints on prescribing patterns on physicians in mainland Europe will result in the uptake of branded antidepressants being reduced. However, antidepressant manufacturers need to focus on US cost constraint measures, as this market ensures continued global growth Key metrics TABLE OF CONTENTS ANTIDEPRESSANT MARKET OVERVIEW Market definition Therapy classes covered Disease indications Epidemiology overview Major depressive disorders Anxiety disorders Antidepressant patient spectrum Antidepressant drug class definitions Serotonergics Noradrenergics TCAs MAOIs Definition of gold standard drug Class comparisons GLOBAL MARKET ANALYSIS Antidepressant market analysis by drug class Overview of global antidepressant market Key trends in the global antidepressant market Serotonergics Overview of the global serotonergic market Key trends in the global serotonergic market Comparison of key brands in the serotonergic class Prozac Paxil Zoloft Celexa Serzone Luvox Noradrenergics Overview of the global noradrenergic market Key trends in the global noradrenergic market Comparison of key brands in the noradrenergic class Effexor Remeron Vestra TCAs Overview of the global TCA market Key trends in the global TCA market MAOIs Overview of the global MAOI market Key trends in the global MAOI market Other antidepressants Overview of the global other antidepressants market Key trends in the global other antidepressants market Wellbutrin SR Other important novel antidepressants COUNTRY ANALYSIS Significance of major countries in the global antidepressant market Overview of the global antidepressant market Three key markets with high opportunity for antidepressant manufacturers Breakdown of the country markets by class Summary of global market factors US Japan Europe The US antidepressant market in 2000 US market by class US market by brand Environmental drivers in the US Japan antidepressant market analysis Japanese market by class Japanese market by brand Environmental drivers in Japan France antidepressant market analysis French market by class French market by brand Environmental drivers in France German antidepressant market analysis German market by class German market by brand Environmental drivers in Germany Italian antidepressant market analysis Italian market analysis by class Italian market by brand Environmental drivers in Italy Spanish antidepressant market analysis Spanish market by class Spanish market by brand Environmental drivers in Spain UK antidepressant market analysis UK market by class UK market by brand Environmental drivers in the UK LIFECYCLE MANAGEMENT Global antidepressant drug class lifecycle Antidepressant reformulations New indications for antidepressant drugs Lifecycle management case studies August 2001: the sudden collapse of Prozac The co-marketing of Remeron SolTab in the US Cipralex: the last SSRI? THE FUTURE DECODED Market forecasting methodology Disease market growth Disease drug class growth Individual drug growth Trends in the antidepressant market to 2008 Global market forecast Impacting events Drug class forecast Global antidepressant market in 2008 Alternative forecast scenarios Scenario 1: SSRIs negative scenario Scenario 2: SSRIs positive scenario APPENDIX Datamonitor's Central Nervous System Business Unit Contributing experts Table of tables Table of figures Bibliography Epidemiolgy Clinical trials Miscellaneous Websites Sales data research methodology Introduction Hypothesis formulation Hypothesis testing Data verification with key contacts Quality control Quantification of data reliability Confidence ratings Exchange rates Patent data (c) Datamonitor 2002. All Rights Reserved. AbstractDatamonitor's Strategic Perspectives 2001: Antidepressant Treatment Strategies - Efficacy Drives Psychiatrist Drug Choice provides a comprehensive review of how psychiatrists in the seven major markets approach the management of mood disorders. The report includes: * Detailed physician perception of each mood disorder drug against a wide variety of factors and in comparison to each other * Overall psychiatrist strategy for the management of mood disorder patients including comorbidites, drug switching and patient failure * Case studies of each major antidepressant, including an analysis of physician usage, perceived unmet need and positioning in comparison to rival drugs * Physician requirements from antidepressant clinical trials and potential impact on prescribing policy * Physician responses to hypothetical drug launches with different characteristics to currently marketed products * Opinion leader comment about vital issues raised in the reportGet Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||